Abstract
GEN EdgeVol. 1, No. 1 Metabolic DisordersDicerna, Novo Nordisk Eye 30+ Liver Targets in Up-to-$3.8B RNAi PartnershipAlex PhilippidisAlex PhilippidisSearch for more papers by this authorPublished Online:21 Nov 2019https://doi.org/10.1089/genedge.1.1.35AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 1Issue 1Jan 2019 Information© 2019 by GEN PublishingTo cite this article:Alex Philippidis.Dicerna, Novo Nordisk Eye 30+ Liver Targets in Up-to-$3.8B RNAi Partnership.GEN Edge.Jan 2019.172-174.http://doi.org/10.1089/genedge.1.1.35Published in Volume: 1 Issue 1: November 21, 2019PDF download
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callSimilar Papers
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
